Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. [electronic resource]
Producer: 20050809Description: 2590-7 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain Neoplasms -- drug therapy
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Skin Neoplasms -- drug therapy
- Survival Rate
- Temozolomide
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.